Document text
Principal Investigator: Jason Matthew Elinoff
Organization: CLINICAL CENTER
Fiscal Year: 2022
Funding agency: NIH Clinical Center
IIn FY21, we determined the expression levels of known and putative host viral entry molecules including angiotensin-converting enzyme 2 (ACE2), transmembrane serine protease 2 (TMPRSS2), neuropilin 1 (NRP1), and DC-SIGNR (CD209L/CLEC4M) in primary human lung endothelial cells (ECs). Results were compared to human embryonic kidney (HEK293) cells, a cell line that is known to be permissive to SARS-CoV-2 entry. Additionally, experiments utilizing both SARS-CoV-2 pseudotyped lentiviral particles as well as live SARS-CoV-2 (WA1/2020) were conducted in various types of primary human ECs and the human Ea.hy926 endothelial line in order to determine whether human ECs were susceptible to SARS-CoV-2 infection in vitro.
The results of this work revealed that primary human pulmonary artery and lung microvascular ECs express low levels of ACE2, TMPRSS2, and CD209L but high levels of NRP1. Neither Wuhan variant pseudotyped nor live USA/WA1 variant SARS-CoV-2 virus appear to generally infect primary human pulmonary ECs in vitro. Furthermore, overexpression of TMPRSS2 with ACE2 in HEK293 cells further increased infection with SARS-CoV-2 pseudotyped lentivirus whereas overexpression of NRP1 with ACE2 or CD209L with ACE2+TMPRSS2 appears to decrease infection compared to ACE2 overexpression alone. In conclusion, low levels of ACE2 and TMPRSS2 expression in cultured primary human lung ECs may explain their diminished susceptibility to SARS-CoV-2 infection. Future work is planned to determine whether overexpression of ACE2 and/or TMPRSS2, cell matrix, circulating factors in COVID+ patient serum or plasma, or different spike protein variants impact human EC susceptibility to infection in vitro.
In FY22, in vitro exposure to increasing concentrations of plasma from hospitalized patients with mild and severe cases of COVID-19 did not consistently increase or decrease ACE2 and NRP1 mRNA expression in primary human pulmonary artery ECs (PAECs). In contrast to wild-type Wuhan variant pseudotyped viral particles, SARS-CoV-2 pseudovirus expressing the D614G spike protein variant successfully entered PAECs (P<0.05 for MOI 2.5 and 5 compared to MOI 0; P<0.05 for the fold increase compared to the Wuhan strain at the same MOI), while alternative variants (N439K and N501Y) did not. Likewise, using immunofluorescent microscopy, recombinant spike protein from the SARS-CoV-2 Delta variant
(contains D614G mutation) dose-dependently entered PAECs while the Wuhan
variant recombinant spike protein did not. Yet following inoculation with either the USA/WA1 strain, an early pandemic isolate carrying the D614G mutation, or the Delta variant of SARS-CoV-2 variant, there was no evidence of viral replication as determined by viral quantification (TCID50) of PAEC supernatants. In summary, while SARS-CoV-2 pseudovirus entry into pulmonary artery endothelium is influenced by spike protein variant expression, SARS-CoV-2 virus does not appear to effectively replicate in primary human pulmonary ECs in vitro.
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><2019-nCoV S protein><2019-nCoV spike glycoprotein><2019-nCoV spike protein><2019-nCoV variant><2019-nCoV variant forms><2019-nCoV variant strains><A5 Antigen><ACE2><Acute><Apoplexy><Apoptosis><Apoptosis Pathway><Autopsy><B.1.617.2><Biologic Models><Biological Models><Blood Coagulation Disorders><Blood Plasma><Blood Serum><Blood Vessels><Brain Vascular Accident><COVID associated pneumonia><COVID induced pneumonia><COVID infected patient><COVID patient><COVID pneumonia><COVID positive patient><COVID related pneumonia><COVID-19><COVID-19 S protein><COVID-19 associated pneumonia><COVID-19 induced pneumonia><COVID-19 infected patient><COVID-19 infection><COVID-19 patient><COVID-19 pneumonia><COVID-19 positive patient><COVID-19 predisposition><COVID-19 related pneumonia><COVID-19 spike glycoprotein><COVID-19 spike protein><COVID-19 susceptibility><COVID-19 variant><COVID-19 variant forms><COVID-19 variant strains><COVID-19 virus><COVID-19 vulnerability><COVID19><COVID19 S protein><COVID19 infection><COVID19 patient><COVID19 positive patient><COVID19 spike glycoprotein><COVID19 spike protein><COVID19 virus><CV-19><CV19><Cardiovascular><Cardiovascular Body System><Cardiovascular Manifestation><Cardiovascular Organ System><Cardiovascular system><Cell Body><Cell Line><Cell model><CellLine><Cells><Cellular model><Cerebral Stroke><Cerebrovascular Apoplexy><Cerebrovascular Stroke><Cessation of life><Chronic><Circulatory Collapse><CoV emergence><CoV-2><CoV2><Coagulation Disorder><Coagulopathy><Coronavirus disease 2019 predisposition><Coronavirus disease 2019 susceptibility><Coronavirus disease 2019 vulnerability><Death><Delta variant><Disease><Disorder><Distal><Dose><Electron Microscopy><Embryo><Embryonic><Endothelial Cells><Endothelium><Epitheliasin Gene><Exposure to><Future><Genes><Genetic Alteration><Genetic Change><Genetic defect><Heart Vascular><Human><Hypoxemic Respiratory Failure><Hypoxic Respiratory Failure><IFN><In Situ Hybridization><In Vitro><Infection><Inflammation><Inflammatory><Inflammatory Infiltrate><Injury><Interferons><Kidney><Kidney Urinary System><Laboratories><Lentivirinae><Lentivirus><Lung><Lung Respiratory System><MIS-C><Microscopy><Model System><Modern Man><Molecular><Multiorgan Inflammatory Syndrome in Children><Multisystem Inflammatory Syndrome in Children><Mutation><NRP1 Protein><Neuropilin-1><Non-Polyadenylated RNA><Npn-1 Protein><Organ><PRSS10><Pathologic><Patients><Phenotype><Plasma><Plasma Serum><Predisposed to COVID-19><Predisposed to SARS-CoV-2><Predisposed to Severe acute respiratory syndrome coronavirus 2><Predisposition><Programmed Cell Death><Proteins><Pulmonary Artery><Pulmonary Hypertension><Pulmonary artery structure><RNA><RNA Gene Products><Recombinants><Reticuloendothelial System, Serum, Plasma><Ribonucleic Acid><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 B.1.617.2><SARS-CoV-2 S protein><SARS-CoV-2 associated pneumonia><SARS-CoV-2 delta><SARS-CoV-2 induced pneumonia><SARS-CoV-2 infected patient><SARS-CoV-2 infection><SARS-CoV-2 patient><SARS-CoV-2 pneumonia><SARS-CoV-2 positive patient><SARS-CoV-2 predisposition><SARS-CoV-2 related pneumonia><SARS-CoV-2 spike glycoprotein><SARS-CoV-2 spike protein><SARS-CoV-2 susceptibility><SARS-CoV-2 variant><SARS-CoV-2 variant forms><SARS-CoV-2 variant strains><SARS-CoV-2 vulnerability><SARS-CoV2><SARS-CoV2 S protein><SARS-CoV2 infection><SARS-CoV2 spike glycoprotein><SARS-CoV2 spike protein><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Secondary to><Sema III Receptor><Semaphorin III Receptor><Serine Endopeptidases><Serine Protease><Serine Protein Hydrolases><Serine Proteinases><Serum><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 S protein><Severe acute respiratory syndrome coronavirus 2 infection><Severe acute respiratory syndrome coronavirus 2 predisposition><Severe acute respiratory syndrome coronavirus 2 spike glycoprotein><Severe acute respiratory syndrome coronavirus 2 spike protein><Severe acute respiratory syndrome coronavirus 2 susceptibility><Severe acute respiratory syndrome coronavirus 2 vulnerability><Severe acute respiratory syndrome related corona virus 2><Shock><Strains Cell Lines><Stroke><Susceptibility><Syndrome><TMPRSS2><TMPRSS2 gene><Testing><Therapeutic Effect><Thrombus><Variant><Variation><Vascular Endothelial Cell Growth Factor 165 Receptor><Vascular Endothelium><Vascular remodeling><Viral><Virus><Virus Replication><Virus-Lenti><Work><Wuhan coronavirus><angiotensin converting enzyme 2><angiotensin converting enzyme II><arteriole><bleeding disorder><brain attack><cerebral vascular accident><cerebrovascular accident><circulatory shock><circulatory system><clinical relevance><clinically relevant><clotting disorder><corona virus disease 2019><corona virus emergence><coronavirus disease 2019><coronavirus disease 2019 S protein><coronavirus disease 2019 associated pneumonia><coronavirus disease 2019 induced pneumonia><coronavirus disease 2019 infected patient><coronavirus disease 2019 infection><coronavirus disease 2019 patient><coronavirus disease 2019 pneumonia><coronavirus disease 2019 positive patient><coronavirus disease 2019 related pneumonia><coronavirus disease 2019 spike glycoprotein><coronavirus disease 2019 spike protein><coronavirus disease 2019 variant><coronavirus disease 2019 variant forms><coronavirus disease 2019 variant strains><coronavirus disease 2019 virus><coronavirus disease associated pneumonia><coronavirus disease induced pneumonia><coronavirus disease infected patient><coronavirus disease patient><coronavirus disease pneumonia><coronavirus disease positive patient><coronavirus disease related pneumonia><coronavirus disease-19><coronavirus disease-19 patient><coronavirus disease-19 pneumonia><coronavirus disease-19 virus><coronavirus emergence><coronavirus infectious disease-19><coronavirus patient><cultured cell line><emergent CoV><emergent corona virus><emergent coronavirus><emerging CoV><emerging corona virus><emerging coronavirus><endothelial dysfunction><experiment><experimental research><experimental study><expression vector><genome mutation><hCoV19><in situ Hybridization Genetics><in situ Hybridization Staining Method><in vitro Model><in vivo><infected with COVID-19><infected with COVID19><infected with SARS-CoV-2><infected with SARS-CoV2><infected with coronavirus disease 2019><infected with severe acute respiratory syndrome coronavirus 2><injuries><lung microvascular endothelial cells><mRNA Expression><mortality><multisystem inflammatory syndrome of children><nCoV><nCoV2><necropsy><new CoV><new corona virus><new coronavirus><novel CoV><novel corona virus><novel coronavirus><overexpress><overexpression><pandemic><pandemic disease><particle><patient infected with COVID><patient infected with COVID-19><patient infected with SARS-CoV-2><patient infected with coronavirus disease><patient infected with coronavirus disease 2019><patient infected with severe acute respiratory syndrome coronavirus 2><patient with COVID><patient with COVID-19><patient with COVID19><patient with SARS-CoV-2><patient with coronavirus disease><patient with coronavirus disease 2019><patient with severe acute respiratory distress syndrome coronavirus 2><pediatric inflammatory multisystem syndrome><pneumonia due to COVID><pneumonia due to COVID-19><pneumonia due to SARS-CoV-2><pneumonia due to coronavirus disease><pneumonia due to coronavirus disease 2019><pneumonia due to severe acute respiratory syndrome coronavirus 2><pneumonia in COVID><pneumonia in COVID-19><pneumonia in SARS-CoV-2><pneumonia in coronavirus disease><pneumonia in coronavirus disease 2019><pneumonia in severe acute respiratory syndrome coronavirus 2><postmortem><predisposed to Coronavirus disease 2019><pulmonary><pulmonary arterial endothelial cell><pulmonary arterial hypertension><pulmonary artery endothelial cell><pulmonary artery hypertension><pulmonary microvascular endothelial cells><renal><severe acute respiratory syndrome coronavirus 2 B.1.617.2><severe acute respiratory syndrome coronavirus 2 associated pneumonia><severe acute respiratory syndrome coronavirus 2 induced pneumonia><severe acute respiratory syndrome coronavirus 2 infected patient><severe acute respiratory syndrome coronavirus 2 patient><severe acute respiratory syndrome coronavirus 2 pneumonia><severe acute respiratory syndrome coronavirus 2 positive patient><severe acute respiratory syndrome coronavirus 2 related pneumonia><severe acute respiratory syndrome coronavirus 2 variant><severe acute respiratory syndrome coronavirus 2 variant forms><severe acute respiratory syndrome coronavirus 2 variant strains><susceptible to COVID-19><susceptible to Coronavirus disease 2019><susceptible to SARS-CoV-2><susceptible to Severe acute respiratory syndrome coronavirus 2><systemic inflammation><systemic inflammatory response><thrombotic><transcriptomics><vascular><vascular inflammation><venous thromboembolism><viral multiplication><viral replication><virus multiplication>